Defective placentation is the underlying cause of various pregnancy complications, such as severe intrauterine growth restriction and preeclampsia. However, studies on human placental development are hampered by the lack of a self-renewing in vitro model that would recapitulate formation of trophoblast progenitors and differentiated subtypes, syncytiotrophoblast (STB) and invasive extravillous trophoblast (EVT), in a 3D orientation. Hence, we established long-term expanding organoid cultures from purified first-trimester cytotrophoblasts (CTBs). Molecular analyses revealed that the CTB organoid cultures (CTB-ORGs) express markers of trophoblast stemness and proliferation and are highly similar to primary CTBs at the level of global gene expression. Whereas CTB-ORGs spontaneously generated STBs, withdrawal of factors for self-renewal induced trophoblast outgrowth, expressing the EVT progenitor marker NOTCH1, and provoked formation of adjacent, distally located HLA-G + EVTs. In summary, we established human CTB-ORGs that grow and differentiate under defined culture conditions, allowing future human placental disease modeling.
INTRODUCTION
During placentation two types of differentiated epithelial trophoblasts arise. In floating villi, bathed in maternal blood, cytotrophoblasts (CTBs) undergo cell fusion thereby forming syncytiotrophoblasts (STBs). The latter represent the brush border between maternal and fetal circulation, transport nutrients and oxygen to the developing embryo, and produce hormones maintaining pregnancy (Aplin, 2010; Evain-Brion and Malassine, 2003) . In villi, anchoring to the maternal decidua, proliferative cell columns give rise to extravillous trophoblasts (EVTs) invading maternal uterine stroma and the spiral arteries (Pijnenborg et al., 1980) . Remodeling of the latter promotes low-pressure blood flow to the developing placenta, thereby adapting oxygen and nutrient supply for fetal growth Pijnenborg et al., 2006) . Abnormal changes in EVT invasion and remodeling have been detected in different pregnancy disorders such as severe forms of intrauterine growth restriction, preeclampsia, miscarriage, recurrent abortion, and preterm labor (Hustin et al., 1990; Khong et al., 1987; Pijnenborg et al., 1991; Romero et al., 2011; Sheppard and Bonnar, 1976; Windsperger et al., 2017) . Defects in EVT progenitor formation and differentiation could represent an underlying cause (Lim et al., 1997; Zhou et al., 1997) . However, human trophoblast models, that adequately mimic these early developmental processes, have not been established. Primary CTBs, isolated from first-trimester placenta, can hardly be manipulated since they rapidly cease proliferation in culture. Alternative models, such as trophoblast cell lines, choriocarcinoma cells, and bone morphogenetic protein 4 (BMP4)-treated human embryonic stem cells (hESCs) have been established. However, global gene expression profiles of BMP4-treated hESCs and trophoblast-specific markers, as well as human leucocyte antigen (HLA) status of the cell lines, diverge considerably from primary tissues (Apps et al., 2009; Bilban et al., 2010; Jain et al., 2017; Lee et al., 2016; Yabe et al., 2016) . Thus, localization and characteristics of human trophoblast stem cells (TSCs) and progenitors during pregnancy remain largely elusive (Chang and Parast, 2017; Gamage et al., 2016) . Previous investigations suggested the presence of bipotential as well as distinct progenitors for syncytialization and EVT formation (Baczyk et al., 2006; Haider et al., 2016; Horii et al., 2016; James et al., 2007) . Very recently, bipotential human TSCs have been isolated from blastocysts and CTB preparations showing longterm, 2D proliferation under defined culture conditions (Okae et al., 2018) . However, development of a system allowing studying 3D cell column formation, growth, and differentiation, as it occurs during in vivo placentation, has not been reported.
Establishment of self-renewing 3D epithelial organoids, closely resembling structure and physiology of the original organ, has been achieved from various tissues containing multipotent stem cells (Boretto et al., 2017; Kessler et al., 2015; Kretzschmar and Clevers, 2016; Turco et al., 2017) .
However, organoids of the human placenta have not been generated so far. Therefore, we herein established human CTB organoid cultures (CTB-ORGs) from purified firsttrimester CTB preparations that are capable of self-renewal and expansion under defined culture conditions. Whereas STBs were spontaneously generated in this system, removal of factors, promoting long-term expansion, provoked development of EVT progenitors and their differentiation. The present model provides evidence for a TSC niche in the villous epithelium of the human placenta. Further, it will allow studying discrete steps of EVT formation in a sequential manner.
RESULTS

Establishment of Long-Term Expanding Human Trophoblast Organoids
To generate human trophoblast organoids, villous cytotrophoblasts (vCTBs), purified from pooled first-trimester placental tissues of the 6th to 7th week of gestation, were embedded in Matrigel containing a mixture of growth factors and signaling inhibitors, previously shown to promote stemness and formation of organoids (Kretzschmar and Clevers, 2016) . Inhibition of transforming growth factor b (TGF-b) and BMP signaling with A83-01 and Noggin, respectively, supplementation of epidermal growth factor (EGF), and activation of Wnt signaling, using R-spondin, the glycogen synthase kinase 3a and 3b (GSK-3a/b) inhibitor CHIR99021 and prostaglandin E2, have been successfully applied for establishing gut and other types of human epithelial organoids (Dutta et al., 2017; Kretzschmar and Clevers, 2016) . Using this defined cocktail of factors, small cell clusters formed within several days of culture, which rapidly grew and developed into organoids with irregular structures after 2-3 weeks ( Figure 1A) . Currently, 16 different organoid cultures were established from early placental tissues (sixth to seventh week) with 100% derivation efficiency, which could be cryo-preserved and re-cultivated. However, we could not generate organoids from five different vCTB preparations of pooled placental tissues of the 10th to 12th week of gestation (data not shown). Organoids were passaged approximately every 14 days and could be expanded for more than 5 months (passage 10 [P10]-P11). At this stage, growth rates were decreasing and organoids could not be reformed after P13. A video showing time-dependent growth (between day 2 and 6) of a representative organoid culture at P2 is depicted (Video S1).
Immunofluorescence revealed that the outer layers of the organoids harbor multiple rows of mononuclear, cytokeratin 7 (KRT7) + cells expressing the CTB marker hepatocyte growth factor activator inhibitor type 1 ( Figure 1B ). The spheroid-like structures also expressed the STB marker chorionic gonadotrophin b (CGb), but completely lacked vimentin, confirming their trophoblast identity (Figures S1A and S1B) . In contrast to the architecture of the placental villous epithelium, the CTB-ORGs show an inverse organization with multinuclear, E-cadherin -cells in the inner part, indicating that the CTBs undergo cell fusion toward the center ( Figure 1B ). As organoids grew in size, CGb expression markedly increased (Figures S1C and S1D). Electron microscopy unraveled formation of a micro-villous membrane on the multinucleated structures indicating that these cells could be very similar to in vivo STBs ( Figure 1C ). Indeed, prominent numbers of transport vesicles in these cells ( Figure 1C ) and detection of CGb in the supernatants of CTB-ORGs ( Figure S1E ) suggested that the multinucleated cells also exhibit secretory activity. The presence of EGF and of the TGF-b signaling inhibitor A83-01, respectively, was found to be critical for longterm expansion of CTB-ORGs ( Figure S2A ), whereas absence of the Wnt inducers (R-spondin and CHIR99021) promoted trophoblast outgrowth and differentiation ( Figures S5A and S5B ). Clonogenic assays revealed that large organoids are formed from single cells within 3-4 weeks ( Figures 1D and S2B ).
Human Trophoblast Organoids Express Markers of Human CTB Stemness, Proliferation, and Cell Fusion To further assess trophoblast origin and maintenance of CTB-ORGs, we analyzed widely accepted transcription factors of human CTB identity, stemness, and differentiation (Hemberger et al., 2010; Lee et al., 2016; Li et al., 2014) (Figure 2) . In agreement with their expression in vCTBs of the 6th-week placenta, we observed that caudal-type homeobox protein 2 (CDX2), tumor protein p63 (TP63), and TEA-domain transcription factor 4 (TEAD4) were expressed in the outer CTB layers of CTB-ORGs ( Figure 2A ). The respective mRNAs were also detectable in CTB-ORGs. Moreover, other regulators of trophoblast development, AP-2a, AP-2g, and GATA3, expressed in STBs and/or CTBs of first-trimester placenta (Biadasiewicz et al., 2011; Paul et al., 2017) , were also present in CTBs of organoids (Figures 2A and 2B) . Cyclin A (CCNA) and KI67, marking proliferative vCTBs in 6th-week placenta, were expressed in the outer CTB layers of CTB-ORGs, but not in the inner STBs ( Figure 2C ). Expression of the ELF5 gene and demethylation of its promoter region were shown to be indicative for human CTB origin (Hemberger et al., 2010; Lee et al., 2016) . The proximal ELF5 promoter was largely hypomethylated in CTB-ORGs and vCTBs, whereas 74% of the CpG sites were methylated in placental fibroblasts (Figure 2D) . Accordingly, ELF5 mRNA was detected in CTBORGs, but absent from the villous stromal cells ( Figure 2B ). To assess long-term self-renewing capacity of CTB-ORGs, mRNA expression of markers of trophoblast identity and stemness were analyzed at low, middle, and high passage numbers ( Figure S3 ). TFAPC, encoding AP-2g, TP63, and ELF5 mRNAs were expressed at similar levels between P1 and P3, P4 and P7, and P8 and P11. TEAD4 and CDX2 transcript levels tended to decrease at P8-P11, whereas GATA3 increased. CCNA mRNA also decreased between P8 and P11, coinciding with the decelerating growth of CTBORGs. Vimentin (VIM) mRNA was undetectable in CTBORGs, indicating that CTB-ORGs do not undergo an abnormal epithelial-to-mesenchymal transition (EMT) upon long-term passaging.
To further characterize inner cells of CTB-ORGs, several markers of syncytialization were investigated ( Figure 3 ). In agreement with the inside-out architecture of CTB-ORGs, poly(U)-specific endoribonuclease (ENDOU), identified as an STB-specific mRNA in the RNA sequencing (RNA-seq) analyses (see below), glial cell missing 1 (GCM1), and CGb were expressed in the outer STB layer of the 6th-week placenta and in the inner layer of CTB-ORGs (Figure 3A) . The respective transcripts GCM1, ENDOU, and CGB could be identified in CTB-ORGs and in STBs, generated by in vitro cell fusion, but were weakly expressed (GCM1) or largely absent (ENDOU, CGB) from purified placental vCTBs ( Figure 3B ). Apoptotic cells were detected in a very small percentage of cells of CTB-ORGs and resided in E-cadherin + CTBs as well as in E-cadherin -STBs ( Figure S4 ).
Gene Expression Profiles of Trophoblast Organoids and Primary Human Trophoblasts Are Highly Similar
To unravel similarities between gene expression profiles, CTB-ORGs and primary vCTBs preparations, freshly isolated (0 hr) or in vitro differentiated for 72 hr (STB), were subjected to RNA-seq and bioinformatic analyses (Figure 4 ). Hierarchical clustering revealed close similarities between the different CTB-ORGs, vCTBs, and in-vitro-generated STBs, whereas the gene expression profiles of placental fibroblasts considerably diverged from the trophoblast cultures ( Figure 4A ). Closer inspection indicated that 47.8% of all trophoblast-upregulated genes (>2-fold change relative to fibroblasts) were common to CTB-ORGs and primary vCTBs, including all markers of CTB identity and Figure S4 .
stemness, TFAP2A, TFAP2C, CDX2, GATA3, TP63, TEAD4, and ELF5 ( Figures 4B and 4C ). Upon comparison of CTBORGs, primary vCTBs, and STBs, 1,042 (26.5%) commonly expressed genes were identified. A heatmap shows relative mRNA levels of trophoblast markers in the different cultures ( Figure 4C ). Gene expression signatures, established herein, are accessible at the GEO database (https://www. ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE109976).
Loss of R-Spondin and CHIR99021 Changes the Cell Fate of Human Trophoblasts
Wnt signaling maintains stemness and proliferation of epithelial cells in different organoid culture systems (Kretzschmar and Clevers, 2016) . To assess its role in CTB-ORG self-renewal, R-spondin and the GSK-3a/b inhibitor, CHIR99021, were omitted from the organoid cultures ( Figure 5 ). Microscopy and immunofluorescence analyses revealed that withdrawal of the Wnt stimulators (indicated as Wnt À condition) promoted trophoblast outgrowth from the outer CTB layers and expression of HLA-G at distal sites of CTB-ORGs ( Figure 5A ). Outgrowth in Wnt À CTB-ORGs continued for up to at least 14 days, whereas organoids became smaller at subsequent stages (Figures S5A and S5B) . Incubation of Wnt À CTB-ORGs with recombinant Wnt3a largely compensated for the loss of R-spondin/ CHIR99021, since it reduced the average area of outgrowth to 11% ( Figure S5C ). Further, the Wnt À condition decreased expression of the Wnt stem cell receptor LGR5 and the CTB self-renewal markers ELF5, TEAD4, CDX2, and TP63 ( Figures 5B and 5C ). In contrast, the EVT markers HLA-G (Kovats et al., 1990; Yelavarthi et al., 1991) , NOTCH2 , PRG2 (Windsperger et al., 2017) , and ERBB2 (Fock et al., 2015) were induced in the absence of Wnt activators ( Figure 5C ). In vitro development of the EVT lineage occurred at the expense of cell fusion since the STB markers ENDOU and CGb decreased ( Figure 5C ). Notably, we also observed upregulation of the cell column marker NOTCH1, a critical regulator of EVT progenitor formation and survival (Haider et al., 2016) , in Wnt À Figure 4 . RNA-Seq and Bioinformatic Analyses of Placental Organoids and Primary Trophoblasts (A) Hierarchical clustering of genome-wide mRNA expression profiles. A total of 7,417 genes, differentially expressed between CTB-ORG cultures (P2 and P4) and FIBs (n = 2 from 6th week), and expression of these genes in vCTB (n = 3 from 6th-to 7th-week placentae) and differentiated STB (n = 3; 6th-to 7th-week placentae) are shown. Analysis is based on p < 0.05. (B) Venn diagram on the left shows that of 2,293 of trophoblastupregulated mRNAs (>2-fold change relative to FIB; p < 0.05), 1,456 were common to CTB-ORG and vCTB. CTB-ORGs also express 1,500 STB-specific mRNAs (Venn diagram on the right-hand side) and share 1,042 common genes with both vCTB and STB. (C) Clustered heatmap depicting selected expression patterns of markers of CTB stemness and cell fusion. TFAP2A and TFAP2C mRNAs encode AP-2a and AP-2g, respectively. CGB5, mRNA of the chorionic gonadotrophin b5 gene; ENDOU, poly(U)-specific endoribonuclease. Figures 5C and 5D ). Similar to the in vivo situation, NOTCH1 + CTBs developed in proximal regions of trophoblast outgrowth, adjacent to distally located HLA-G + EVTs ( Figure 5D ). Notably, CCNA mRNA expression transiently increased upon loss of R-spondin and CHIR99021 ( Figure S6A ). Like KI67, CCNA protein was predominantly detected in NOTCH1 + CTBs in the absence of Wnt stimulators ( Figure S6B ). These data suggest that Wnt À organoids mirror in vivo cell column/EVT progenitor formation and EVT differentiation in an equivalent 3D orientation.
CTB-ORGs (
Expression of Key Components of Canonical Wnt Signaling in Human First-Trimester Placenta and Organoids Differs between Trophoblast Subtypes
Although previous studies suggested a role for Wnt signaling in EVT function and differentiation (Meinhardt et al., 2014; Pollheimer et al., 2006) , the present data also indicated its importance in vCTB stemness. To further delineate the possible dual role of Wnt in placental development, we evaluated the expression patterns of key components of canonical Wnt signaling in first-trimester placental tissues ( Figure S7 ) and CTB-ORGs (Figure 6 ). In (legend continued on next page) 6th-week placentae nuclear b-catenin was detected in a small number of vCTBs and EVTs of the distal cell column, but absent from NOTCH1 + progenitors ( Figure S7A ). Similarly, a minor fraction of proliferative CTBs (Wnt + ) and HLA-G + EVTs (Wnt À ) of CTB-ORGs revealed nuclear b-catenin expression ( Figure 6A ). In contrast, NOTCH1 + CTB nuclei of Wnt À CTB-ORGs were negative for b-catenin.
Moreover, distinct expression patterns of T cell factors (TCFs), the key transcription factors of canonical Wnt signaling, could be observed in the different trophoblast subtypes. In first-trimester placenta, TCF-1 was expressed in a subset of E-cadherin + vCTBs, but undetectable in NOTCH1 + progenitors and EVTs of the distal cell column ( Figure S7B ). TCF-3 and -4 were absent from vCTBs and proximal cell column trophoblasts of early placental tissues, but present in EVTs adjacent to the NOTCH1 + cells ( Figure S7B ). Expression patterns of TCF mRNAs in purified vCTBs and EVTs reflected protein distribution in tissues ( Figure S7C ). In Wnt-stimulated CTB-ORGs, 
Inhibition of Wnt Response Blocks Extravillous Trophoblast Formation in Human Placental Organoids
To further assess the putative dual role of Wnt signaling in CTB-ORGs, cultures were treated with inhibitor of Wnt response 1 (IWR-1), 2 days after withdrawal of the Wnt stimulators ( Figure 7) . The chemical inhibitor IWR-1 was shown to specifically increase Axin protein levels, thereby enhancing b-catenin phosphorylation and degradation (Chen et al., 2009) . As expected, incubation with IWR-1 did not affect growth of Wnt + CTB-ORGs, since elevated Axin levels cannot abolish CHIR99021-mediated inhibition of GSK-3b and, as a consequence, b-catenin stabilization ( Figure 7A ). However, the Wnt À condition provoked trophoblast outgrowth, as shown above (Figures 5 and S5) , and subsequent incubation with IWR-1 prevented EVT formation. Notably, NOTCH1 + progenitors accumulated upon supplementation of Wnt À organoids with IWR-1, whereas only few HLA-G + EVTs could be detected ( Figure 7B ). In summary, exogenous stimulation of Wnt signaling was necessary for self-renewal of CTB-ORGs, whereas removal of the Wnt activators promoted EVT progenitor development ( Figure 7C ). Upon differentiation of the latter endogenous Wnt signaling could be activated, promoting EVT formation in an autocrine fashion, as has been demonstrated in 2D cultures (Meinhardt et al., 2014; Pollheimer et al., 2006) .
DISCUSSION
Development of the human placenta and its different trophoblast subtypes remains poorly understood. Ethical constraints to obtain placental tissue from early pregnancy, as well as the lack of appropriate culture conditions, promoting trophoblast self-renewal, strongly hindered scientific progress. Therefore, localization of human trophoblast stem and progenitor cells in early placental tissues, and their specific features, are largely unknown (Chang and Parast, 2017; Gamage et al., 2016; Roberts and Fisher, 2011) . Previously, human TSC-like line and trophoblast progenitors have been derived from single embryonic blastomeres of embryos and the chorionic mesenchyme, respectively, using 10% fetal bovine serum, fibroblast growth factor 2 (FGF2), and inhibition of TGF-b/Activin/ Nodal signaling (Genbacev et al., 2011; Zdravkovic et al., 2015) . These data suggested that the TSC niche could be specified before blastocyst formation and might reside outside the placental epithelium at later stages of pregnancy. Supplementation of the above-mentioned ingredients was based on mouse studies showing that stimulation of FGF4 signaling promotes TSC growth, whereas inhibition of the TGF-b pathway decreased expression of the pluripotency markers OCT4 and NANOG in hESCs and induced trophoblast differentiation (Tanaka et al., 1998; Wu et al., 2008) . However, in contrast to mice, FGF receptors are absent from human blastocysts (Kunath et al., 2014) , suggesting that other developmental signaling pathways could be necessary for maintenance of human TSCs. Indeed, recent data suggested that activation of EGF and Wnt as well as inhibition of histone deacetylases, Rho-associated kinase, and TGF-b signaling was sufficient for long-term 2D self-renewal of TSCs from human blastocysts (Okae et al., 2018) . These cells could also be derived from primary CTB preparations, providing evidence for localization of the TSC niche in the placental epithelium (Okae et al., 2018) . The present study supports this view.
(C) qPCR analyses showing TCF7 (encoding TCF-1), TCF7L1 (encoding TCF-3), and TCF7L2 (encoding TCF-4) mRNA expression (normalized to TBP) in different Wnt + and Wnt À CTB-ORGs (n = 5, P2-P4). Mean values ± SD, measured in duplicates, are shown *p < 0.05; AU, arbitrary units. See also Figure S7 . Using a defined cocktail of growth factors and inhibitors, shown to promote organoid growth of various types of adult epithelial stem cells (Dutta et al., 2017; Kretzschmar and Clevers, 2016) , we derived long-term expanding CTB-ORGs from sixth-to seventh-week placentae. Notably, organoids could not be established from tissues of the 10th to 12th weeks, suggesting that expandable TSCs might be absent at later stages of pregnancy. The proliferative 3D structures of early placenta express markers of human CTB stemness in the outer epithelial cell layers and spontaneously undergo cell fusion toward the center, thereby generating functionally active, CGb-secreting STBs. Genome-wide mRNA expression profiling revealed great similarities of CTB-ORGs to freshly isolated vCTBs as well as to STBs generated by 2D in vitro differentiation. Proliferation progressively declined from outside to inside of CTB-ORGs. Hence, we speculate that, similar to the 2D primary cultures, the absence of proliferation in the inner part of CTB-ORGs could promote cell fusion.
Based on previously established criteria for human trophoblast origin (Hemberger et al., 2010; Lee et al., 2016; , CTB-ORGs were shown to express marker genes for CTB stemness and identity. Besides TP63, promoting vCTB proliferation , ELF5 was continuously expressed upon passaging of CTBORGs. The ELF5 gene promoter was found to be hypomethylated in CTB-ORGs, another indication for their trophoblast origin (Hemberger et al., 2010; Lee et al., 2016) . AP-2a, AP-2g, and GATA3, restricted to trophoblasts in first-trimester placenta (Biadasiewicz et al., 2011; Paul et al., 2017) , were also present in CTB-ORGs. GATA3 is also expressed in STBs of placental tissues (Paul et al., 2017) , providing an explanation for the increasing GATA3 mRNA levels at long-term passaging of CTBORGs, which accompanies the rising CGb levels in these cultures. TEAD4, an activator of Cdx2 expression and trophectoderm (TE) development in mice (Nishioka et al., 2009; Yagi et al., 2007) , was also detected in the majority of CTB nuclei of CTB-ORGs.
The key regulator of murine trophoblast development, Cdx2 (Strumpf et al., 2005) , was shown to be weakly produced by a subset of human TE cells (Deglincerti et al., 2016) . In early placentae it is absent from cell columns and appears in clusters of vCTBs, particularly in regions closer to the chorionic plate (Haider et al., 2016; Horii et al., 2016; Soncin et al., 2018) . Herein, CDX2 was only detected in a small number of CTBs of organoids, and its mRNA was weakly expressed, as in the previously established human TSCs (Okae et al., 2018) . The heterogeneous distribution of the factor in the placenta could explain the low yield of CDX2 + cells in CTB isolations, likely containing higher amounts of distal villi lacking CDX2 (Haider et al., 2016) . Notably, its mRNA levels tended to decrease at high passage numbers of CTB-ORGs, suggesting that the low-abundant CDX2 + cell population eventually cannot be maintained long-term. CDX2 + cells could represent another trophoblast subtype, for example residual TE stem cells, which require different conditions for continuous cell proliferation. However, cyclin A expression also declined at high passage numbers. Hence, a decline of transcription factors, associated with trophoblast stemness, by trend might also be explained by the diminishing proliferative capacity of CTB-ORGs. Loss of expandability of CTBORGs after P13 might indicate that the culture conditions for long-term self-renewal could be further improved. On the other hand, CTB-ORGs could not be established from placental tissues of the late first trimester. Hence, TSCs might have a limited lifespan in vivo, which could account for the loss of self-renewal upon long-term passaging of CTB-ORGs. Indeed, organoids derived from several other tissues also cease proliferation at higher passage numbers (Lee et al., 2018; Loomans et al., 2018) . Nevertheless, our molecular analyses provide evidence for a self-renewing, Wnt-dependent vCTB precursor population in CTBORGs. These cells have the capacity to fuse, but also to form NOTCH1 + EVT progenitors upon loss of Wnt stimulation, and could therefore be regarded as bipotential CTB stem cells. Wnt signaling in adult stem cells and organoids controls self-renewal, lineage specification and differentiation (Frank et al., 2016; Kretzschmar and Clevers, 2017) . Previous data suggested that it also plays a pivotal role in human placental development (Knöfler and Pollheimer, 2013; Sonderegger et al., 2010) . Here, we show that the exogenous stimulation of Wnt signaling maintained growth of CTB-ORGs, coinciding with the expression of LGR5, nuclear b-catenin, and TCF-1. The latter, expressed in a subset of vCTBs, was shown to control self-renewal of different stem cells types (Huls et al., 2013; Yi et al., 2011) . Since TCF-3 and -4 proteins were undetectable in proliferative CTBs of tissues and organoids, we speculate that TSC proliferation could be mainly triggered by nuclear b-catenin-TCF-1 complexes. Notably, self-renewal in CTB-ORGs was not maintained in the absence of the Wnt stimulators, suggesting that the endogenous, autocrine Wnt loops are not sufficient for long-term CTB proliferation, despite the expression of different Wnt ligands in vCTBs (Sonderegger et al., 2007) . Withdrawal of R-spondin and CHIR99021 promoted a transient increase in cyclin A expression, trophoblast outgrowth, and development of proliferative NOTCH1 + progenitors. The latter likely develop into HLA-G + EVTs, as has been recently shown in 2D cultures (Haider et al., 2016) . At later stages the overall proliferative capacity and size of Wnt À CTB-ORGs organoid decreased, suggesting that TSCs could not be maintained under these conditions. Noteworthy, NOTCH1 + progenitors of Wnt À CTB-ORGs and cell columns in vivo lack nuclear b-catenin as well as expression of TCF-1, -3, and -4, indicating that canonical Wnt signaling could be dispensable for their growth. In contrast, all EVTs in situ express TCF-3 and -4, as well as nuclear b-catenin in approximately 8% of cells (Pollheimer et al., 2006) . During 3D differentiation of CTB-ORGs, some of the EVT nuclei accumulated nuclear b-catenin, whereas its membranous staining decreased. Developing EVTs of Wnt À organoids also induced nuclear TCF-3 and -4 in an autocrine fashion, as also previously noticed in primary CTBs differentiating on a 2D matrix (Meinhardt et al., 2014; Pollheimer et al., 2006) . Since TCF-1 is absent from EVTs and TCF-3 is only weakly expressed, induction of TCF-b-catenin activity could be mostly achieved by the increase of nuclear TCF-4 expression, accompanying the EMT-like process of these cells (Meinhardt et al., 2014) . Along those lines, NOTCH1 + progenitors accumulated, whereas EVTs poorly formed when CTB-ORGs were treated with IWR-1, 2 days after removal of R-spondin and CHIR99021. Thus, the data suggest that exogenous reinforcement of Wnt signaling could promote long-term expansion of TSCs in CTB-ORGs, whereas autocrine activation of the pathway likely controls EVT formation and the specific features of these cells, such as invasion and migration (Meinhardt et al., 2014; Pollheimer et al., 2006) . In conclusion, the present study shows that EGF signaling, inhibition of TGF-b, and reinforcement of the Wnt pathway is required for long-term expansion of CTBORGs. Removal of Wnt stimulators decreases vCTB selfrenewal and induces development of proliferative EVT progenitors lacking nuclear b-catenin and TCFs. The NOTCH1 + progenitors could give rise to adjacent EVTs, reactivating canonical Wnt-b-catenin-TCF activity in an autocrine fashion. Hence, CTB-ORGs develop in a 3D arrangement, mimicking the sequential molecular steps of in vivo cell column formation and differentiation. Follow-up studies will be necessary to further optimize culture conditions for trophoblast self-renewal, specification, and differentiation in CTB-ORGs.
EXPERIMENTAL PROCEDURES
Tissue Collection
First-trimester placentae (sixth to seventh week of gestation) were obtained from elective pregnancy terminations. Utilization of tissues and all Experimental Procedures were approved by the Medical University of Vienna ethics boards (no. 084/2013) and required written informed consent.
Trophoblast Organoid Formation and Cultivation
Villous CTBs were purified from 6th-to 7th-week placentae as mentioned in Supplemental Experimental Procedures. Cells were re-suspended in ice-cold 0.5 mL basic trophoblast organoid medium (b-TOM) containing advanced DMEM/F12 (Invitrogen), 10 mM HEPES, 13 B27 (Gibco), 13 N2 (Gibco), and 2 mM glutamine (Gibco), centrifuged for 3 min at 1,000 rpm, and re-suspended in ice-cold advanced trophoblast organoid medium (a-TOM) consisting of b-TOM supplemented with 100 ng/mL R-spondin (PeproTech), 1 mM A83-01 (R&D Systems), 100 ng/mL recombinant human epidermal growth factor (rhEGF, R&D Systems), 50 ng/mL recombinant murine hepatocyte growth factor (rmHGF, PeproTech), 2.5 mM prostaglandin E2 (R&D Systems), 3 mM CHIR99021 (Tocris), and 100 ng/mL Noggin (R&D Systems). EGF, Wnt stimulators (R-spondin, CHIR99021, and prostaglandin E2) and inhibition of TGF-b signaling (A83-01) were critical for maintenance of organoids. Removal of Noggin or HGF, respectively, showed marginal effects on organoid growth, but were left in the cultures to eventually limit differentiation and promote trophoblast survival (Dash et al., 2005) . Growth factor-reduced Matrigel (GFR-M, Corning) was added to reach a final concentration of 60%. Solution (40 mL) containing 10 5 vCTBs was placed in the center of 24-well plates. After 2 min at 37 C, the plates were turned upside down to ensure equal spreading of the cells in the solidifying GFR-M-forming domes. After 15 min, the plates were turned again and the domes were carefully overlaid with 500 mL prewarmed a-TOM. Organoids were allowed to form for 4-6 days at P0. Bright-field and phase contrast images of organoid cultures were taken using EVOS FL Cell Imaging System microscope (Life Technologies). To generate videos of growing organoids, bright-field images were taken every 90 min with the Lionheart automated live cell imager system (BioTek) and processed using Gen5 software (BioTek). Organoids could be formed from all placentae when using tissue of the sixth to seventh week of gestation. For additional description of methods see Supplemental Experimental Procedures.
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